Literature DB >> 25250131

Screening of cervical cancer: barriers and facilitators.

Saurabh R Shrivastava1, Prateek S Shrivastava1, Jegadeesh Ramasamy1.   

Abstract

Entities:  

Year:  2013        PMID: 25250131      PMCID: PMC4142928     

Source DB:  PubMed          Journal:  Iran J Cancer Prev        ISSN: 2008-2398


× No keyword cloud information.
To the Editor: Cervical cancer is highly preventable with the use cervical cancer screening tools, and can be easily treated if detected at early stages [1]. Worldwide, cervical cancer is the second most common cause of cancer associated mortality [2]. Though incidence of cervical cancer has reduced in last three decades in the developed nations, it still contributed to 200,000 deaths of women in the year 2010, of whom 46,000 were in the reproductive age group and from developing countries [2, 3]. The observed reduction in incidence is mainly because of widespread application of cervical cancer screening with the Papanicolaou (Pap) test [3]. Different national organizations have issued guidelines for screening and surveillance of cervical cancer [4, 5]. The new guidelines recommend initiation of screening with pap smear at age 21, and repeat it after every three years in women age 21 to 29. For women age 30 and older should be screened by combined pap smear and Human Papilloma Virus (HPV) testing, and should be re-screened every five years if both tests are negative [5]. However, these guidelines are based on multiple factors and thus cannot be easily recalled by healthcare providers as a result of which many women do not receive the benefits of screening [6]. However, under-utilization of the screening methods persists as a major challenge as almost 60% of cervical cancers have been diagnosed in those women who have not been screened in last three years [7]. In a Turkey-based study, only 14.6% of women utilized the service of pap-smear testing [8]. Study findings across the globe has revealed that multiple factors (viz. rural residence; no family physician; poor knowledge; low education status; acceptability by the healthcare providers; lesbians sub-groups of women; etc.) have predicted the underutilization of screening methods [9-11]. The utilization of pap smear has been found to be positively associated with education status of the women, persistent motivation to act and the caring nature of the clinician [12]. To counter the challenge of under-utilization of screening methods of cervical cancer, different strategies have been proposed and implemented with variable extent of success. Findings of a review concluded that HPV self-collected testing resulted in marked improvement in the participation of women in cervical cancer screening programs [13]. Employment of tele-medicine technique in screening of cervical cancer has been advocated to overcome geographic barriers for rural women [14]. Other measures like organization of pap test week clinics [15]; HPV vaccination [16]; health education- counseling [17]; and economic incentives [18]; can be implemented based on the needs in local settings. To conclude, for ensuring proper utilization of screening services and better management of cervical cancer patients, there is an immense need for political commitment and specific public health interventions targeted towards educating the community about the risks of cervical cancer, benefits of screening method and implementation of newer strategies to overcome barriers. Furthermore, the message conveyed during awareness campaigns should be socio-culturally acceptable for increasing the utilization of cervical cancer screening among the women of lower socio-economic class.
  16 in total

Review 1.  Overcoming the barriers to HPV vaccination in high-risk populations in the US.

Authors:  Levi S Downs; Isabel Scarinci; Mark H Einstein; Yvonne Collins; Lisa Flowers
Journal:  Gynecol Oncol       Date:  2010-03-29       Impact factor: 5.482

2.  Barriers to cervical cancer screening among Haitian immigrant women in Little Haiti, Miami.

Authors:  Janelle Menard; Erin Kobetz; Jennifer Cudris Maldonado; Betsy Barton; Jenny Blanco; Joshua Diem
Journal:  J Cancer Educ       Date:  2010-12       Impact factor: 2.037

Review 3.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis.

Authors:  Andrea R Spence; Patricia Goggin; Eduardo L Franco
Journal:  Prev Med       Date:  2007-06-22       Impact factor: 4.018

4.  Barriers to cervical cancer screening among lesbians.

Authors:  J Kathleen Tracy; Alison D Lydecker; Lynda Ireland
Journal:  J Womens Health (Larchmt)       Date:  2010-02       Impact factor: 2.681

5.  Protection from cancer and early diagnosis applications in Izmir, Turkey: a pilot study.

Authors:  Ahsen Sirin; Senay Unsal Atan; Emel Tasci
Journal:  Cancer Nurs       Date:  2006 May-Jun       Impact factor: 2.592

6.  Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination.

Authors:  Mélanie Drolet; Marie-Claude Boily; Christina Greenaway; Shelley L Deeks; Caty Blanchette; Jean-François Laprise; Marc Brisson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

7.  Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives.

Authors:  A C Marcus; C P Kaplan; L A Crane; J S Berek; G Bernstein; J E Gunning; M W McClatchey
Journal:  Med Care       Date:  1998-03       Impact factor: 2.983

Review 8.  Cervical cancer screening: what's new and what's coming?

Authors:  Xian Wen Jin; Laura Lipold; Margaret McKenzie; Andrea Sikon
Journal:  Cleve Clin J Med       Date:  2013-03       Impact factor: 2.321

9.  Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria.

Authors:  E O Ugwu; S N Obi; P C Ezechukwu; I I Okafor; A O Ugwu
Journal:  Niger J Clin Pract       Date:  2013 Apr-Jun       Impact factor: 0.968

10.  Changes in cervical cancer screening behavior for women attending Pap Test Week clinics.

Authors:  V Poliquin; K Decker; Ad Altman; R Lotocki
Journal:  Int J Womens Health       Date:  2013-04-08
View more
  2 in total

Review 1.  Facilitating Factors and Barriers of Women's Cancer Screening in Iran: A Systematic Review.

Authors:  Sulmaz Ghahramani; Hengameh Kasraei; Saeed Shahabi; Kamran Bagheri Lankarani
Journal:  Int J Prev Med       Date:  2020-12-11

2.  Exploring the barriers to Pap smear test in Iranian women: a qualitative study.

Authors:  Tayebeh Marashi; Seyed Fahim Irandoost; Javad Yoosefi Lebni; Goli Soofizad
Journal:  BMC Womens Health       Date:  2021-08-06       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.